Caerulein and cholecystokinin reverse experimental hemorrhagic shock

Neuropeptides. 1986 Jul;8(1):25-31. doi: 10.1016/0143-4179(86)90061-2.

Abstract

Intravenously injected cholecystokinin octapeptide (CCK-8) (5-20/micrograms/kg) and caerulein (1.25-10/micrograms/kg) caused a prompt, dose-dependent and sustained improvement in blood pressure, pulse amplitude and survival in rats subjected to otherwise invariably fatal hemorrhagic shock.

MeSH terms

  • Animals
  • Blood Pressure / drug effects
  • Ceruletide / administration & dosage
  • Ceruletide / pharmacology
  • Ceruletide / therapeutic use*
  • Female
  • Injections, Intravenous
  • Rats
  • Rats, Inbred Strains
  • Shock, Hemorrhagic / drug therapy*
  • Sincalide / administration & dosage
  • Sincalide / pharmacology
  • Sincalide / therapeutic use*

Substances

  • Ceruletide
  • Sincalide